Postal Ballot: Preferential shares to promoters and director re-appointment approved

Fund Raising View source PDF Explain this filing

VASWANI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹54.50

prior close

₹54.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-2.0% vs market

Ferrous Metals peers, median of 23sector · industry level+1.4%-2.0% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.0 pts less than its Ferrous Metals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.9

15m

+0.8

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+1.4-2.0+1.4-2.0

Next day

-1.0+1.5-2.5+1.1-2.1

-1.8+0.5-2.3+0.5-2.3

-1.3+1.1-2.5+0.5-1.9

-1.0+0.7-1.7+0.3-1.3

-2.8-0.4-2.3-0.2-2.5

-3.7+0.5-4.2+0.6-4.3

15d

-6.1+0.1-6.1+3.6-9.7

-3.1+3.5-6.6+3.0-6.1

-15.6+5.8-21.4+5.3-20.9

-21.1+2.4-23.5-1.8-19.3

UpDownMarket · Nifty Microcap 250Sector · Ferrous Metals peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vaswani Industries shareholders approved two special resolutions via postal ballot. First, issuance of equity shares on preferential basis to the promoter and promoter group passed with 99.99 percent of votes in favour (36 members, 1.89 crore shares). Second, re-appointment of independent director Rituraj Peswani for a second five-year term also passed with 99.99 percent support. Overall 57.44 percent of outstanding shares participated in voting, and promoters voted 100 percent in favour.

Likely market impact

Promoter group equity infusion approved, boosting promoter holding. Director continuity maintained. Both passed with near-unanimous shareholder support.